TapewireFind a company

person · Reporting owner

Dillione Janet

Disclosed activity across 1 company

Tapewire entity
68706
SEC CIK
0001489798

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CorMedix Inc.CRMD · Entity 5280DirectorJanuary 26, 2026January 27, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CorMedix Inc.

Report date January 26, 2026 · Filed January 27, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect68,926 Reported balance After 2026-01-26 transaction · row 1
1 source row

Row 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 68,926

F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
January 26, 2026 Filed Jan 27, 2026 21:30 UTC CorMedix Inc. CRMD · Entity 5280 GrantCommon Stock 30,453 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-008476 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,926

F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Read SEC document
January 21, 2026 Filed Jan 22, 2026 21:30 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 10,000 $6.88 $68,800.00
Disclosure

SEC source: 0001213900-26-006876 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected

Read SEC document
December 09, 2025 Filed Dec 11, 2025 08:38 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 15,000 $0.00 Strike: $5.63 $0.00
Disclosure

SEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 5

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on 02/25/2020. These options are fully vested.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 08:38 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 19,000 $0.00 Strike: $9.55 $0.00
Disclosure

SEC source: 0001213900-25-120378 · ownership.xml · derivative · entry 4

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,000 shares

Expires 2026-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 02/21/2016. These options are fully vested.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 08:38 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 34,000 $12.00 $408,000.00
Disclosure

SEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 3

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected

Read SEC document
December 09, 2025 Filed Dec 11, 2025 08:38 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 15,000 $5.63 $84,450.00
Disclosure

SEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 08:38 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 19,000 $9.55 $181,450.00
Disclosure

SEC source: 0001213900-25-120378 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 19,323 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 7

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 19,323 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 15,124 $0.00 Strike: $4.43 $0.00
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 6

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,124 shares

Expires 2033-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 12,210 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · derivative · entry 5

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,210 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 46,657 $10.00 $466,570.00
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 4

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,473

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 19,323 $3.55 $68,596.65
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 3

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 15,124 $4.43 $66,999.32
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,807

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 12,210 $4.03 $49,206.30
Disclosure

SEC source: 0001213900-25-118433 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 5,677 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 9

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,323

Underlying: Common Stock · 5,677 shares

Expires 2034-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on 03/05/2024. These options are fully vested.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 4,876 $0.00 Strike: $4.43 $0.00
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 8

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,124

Underlying: Common Stock · 4,876 shares

Expires 2033-01-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options were granted on 01/14/2023. These options are fully vested.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 7,790 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 7

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,210

Underlying: Common Stock · 7,790 shares

Expires 2032-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options were granted on 02/22/2022. These options are fully vested.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 8,000 $0.00 Strike: $2.85 $0.00
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · derivative · entry 6

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,000 shares

Expires 2028-02-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options were granted on 02/16/2018. These options are fully vested.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 26,343 $9.93 $261,585.99
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 5

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 5,677 $3.55 $20,153.35
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 4

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 4,876 $4.43 $21,600.68
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 3

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 7,790 $4.03 $31,393.70
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 21:30 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionCommon Stock 8,000 $2.85 $22,800.00
Disclosure

SEC source: 0001213900-25-115725 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 14, 2025 Filed Nov 18, 2025 21:45 UTC CorMedix Inc. CRMD · Entity 5280 SaleCommon Stock 30,000 $11.42 $342,600.00
Disclosure

SEC source: 0001213900-25-112316 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,473

F1 · price: This transaction was executed in multiple trades at prices ranging from $11.41 to $11.44, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 21:08 UTC CorMedix Inc. CRMD · Entity 5280 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-005672 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,473

F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date.

Read SEC document
March 05, 2024 Filed Mar 20, 2024 16:25 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 30,000 $0.00 Strike: $3.55 $0.00
Disclosure

SEC source: 0000899140-24-000323 · form4.xml · derivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-03-05

F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
January 14, 2023 Filed Jan 18, 2023 19:01 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $4.43 $0.00
Disclosure

SEC source: 0001213900-23-003554 · ownership.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2033-01-14

F1 · derivative.exercise_date: These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
February 22, 2022 Filed Feb 23, 2022 17:43 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $4.03 $0.00
Disclosure

SEC source: 0000929638-22-000532 · form4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-02-22

F9 · derivative.exercise_date: These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 20:16 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 30,000 $0.00 Strike: $8.32 $0.00
Disclosure

SEC source: 0001213900-21-002060 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-01-11

F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
November 16, 2020 Filed Nov 18, 2020 16:16 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 3,583 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-20-037972 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,583

Underlying: Common Stock · 3,583 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 19:15 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 4,770 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-20-022574 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,770

Underlying: Common Stock · 4,770 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
May 15, 2020 Filed May 18, 2020 16:27 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 5,253 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-20-012825 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,253

Underlying: Common Stock · 5,253 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 21:48 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 15,000 $5.63 Strike: $5.63 $84,450.00
Disclosure

SEC source: 0001213900-20-004981 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2030-02-25

F1 · derivative.exercise_date: These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
February 14, 2020 Filed Feb 19, 2020 16:18 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 1,706 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-20-004256 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

Underlying: Common Stock · 1,706 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
February 14, 2020 Filed Feb 20, 2020 17:05 UTC Amendment CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 1,706 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-20-004441 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706

Underlying: Common Stock · 1,706 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
November 14, 2019 Filed Nov 18, 2019 17:21 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 2,099 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-19-023937 · doc4.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,099

Underlying: Common Stock · 2,099 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
August 16, 2019 Filed Aug 16, 2019 16:07 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 6,147 $8.19 $50,343.93
Disclosure

SEC source: 0001213900-19-016167 · ownership.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,473

F1 · price: Represents the weighted average purchase price of the shares purchased ranging from a low of $8.179 to a high of $8.199 per share.

Read SEC document
August 14, 2019 Filed Aug 16, 2019 16:07 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 945 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-19-016167 · ownership.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 945

Underlying: Common Stock · 945 shares

Expires not disclosed

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
May 15, 2019 Filed May 17, 2019 09:24 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 1,126 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001654954-19-006225 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226

Underlying: Common Stock · 226 shares

Expires not disclosed

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
May 15, 2019 Filed May 17, 2019 09:24 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 11,144 $6.74 $75,110.56
Disclosure

SEC source: 0001654954-19-006225 · section16.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,326

F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $6.72 to a high of $6.74 per share.

F8 · balance_after: The issuer effected a 1-for-5 reverse stock split on March 26, 2019. All share and per share amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.

Read SEC document
March 18, 2019 Filed Mar 20, 2019 16:21 UTC CorMedix Inc. CRMD · Entity 5280 PurchaseCommon Stock 42,000 $1.67 $69,972.00
Disclosure

SEC source: 0001654954-19-002991 · section16.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,909

F1 · price: Represents the weighted average purchase price of the shares purchased from a low of $1.655 to a high of $1.670 per share.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 16:02 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 4,213 $1.78 Strike: $0.00 $7,499.14
Disclosure

SEC source: 0001654954-19-001754 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,213

Underlying: Common Stock · 4,213 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 16:10 UTC CorMedix Inc. CRMD · Entity 5280 GrantStock Option (Right to Buy Common Stock) · Derivative 75,000 $0.00 Strike: $1.66 $0.00
Disclosure

SEC source: 0001654954-19-000378 · section16.xml · derivative · entry 3

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-01-10

F2 · derivative.exercise_date: These options were granted on 01/10/2019. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 16:10 UTC CorMedix Inc. CRMD · Entity 5280 GrantRestricted Stock Units 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001654954-19-000378 · section16.xml · nonDerivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,909

F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.

Read SEC document
January 10, 2019 Filed Jan 11, 2019 16:10 UTC CorMedix Inc. CRMD · Entity 5280 GrantRestricted Stock Units 12,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001654954-19-000378 · section16.xml · nonDerivative · entry 1

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,909

F1 · price: These shares consist of restricted stock units granted on 01/10/2019. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 16:07 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 6,637 $1.13 Strike: $0.00 $7,499.81
Disclosure

SEC source: 0001654954-18-012892 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,637

Underlying: Common Stock · 6,637 shares

Expires not disclosed

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
November 14, 2018 Filed Nov 30, 2018 16:21 UTC Amendment CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 6,637 $1.13 Strike: $0.00 $7,499.81
Disclosure

SEC source: 0001654954-18-013416 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,637

Underlying: Common Stock · 6,637 shares

Expires not disclosed

F2 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F2 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
August 14, 2018 Filed Aug 16, 2018 16:01 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 13,636 $0.55 Strike: $0.00 $7,499.80
Disclosure

SEC source: 0001654954-18-009262 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,636

Underlying: Common Stock · 13,636 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
May 15, 2018 Filed May 17, 2018 16:01 UTC CorMedix Inc. CRMD · Entity 5280 GrantPhantom Stock · Derivative 37,500 $0.20 Strike: $0.00 $7,500.00
Disclosure

SEC source: 0001654954-18-005595 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.

Read SEC document
February 21, 2018 Filed Mar 22, 2018 16:01 UTC CorMedix Inc. CRMD · Entity 5280 Exercise / conversionRestricted Stock Units · Derivative 15,357 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001654954-18-002932 · section16.xml · derivative · entry 2

Dillione Janet · CIK 0001489798 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,357 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018.

F1 · derivative.expiration_date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.